Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "biotechnology"

583 News Found

Indian scientists develop AI-enabled tech for biomedical diagnostic applications
Medical Device | May 28, 2026

Indian scientists develop AI-enabled tech for biomedical diagnostic applications

The platform created by NIT Rourkela researchers is capable of delivering rapid, accurate, and repeatable imaging results with minimal human intervention


Tecan launches direct India operations
News | May 27, 2026

Tecan launches direct India operations

The move signals a major expansion milestone for the Swiss laboratory automation company


Amgen appoints Madhur Sarin as Director – AI & Data Science COE
People | May 26, 2026

Amgen appoints Madhur Sarin as Director – AI & Data Science COE

Sarin will focus on advancing scalable AI-driven platforms and strengthening the company’s global data science capabilities across healthcare and enterprise technology domains


Enveric reports key safety milestone for EB-003 reinforcing clinical development path
Biotech | May 25, 2026

Enveric reports key safety milestone for EB-003 reinforcing clinical development path

The findings support the continued advancement of EB-003, a first-in-class neuroplastogen designed to selectively target both 5-HT2A and 5-HT1B receptors


WACKER launches contract research services to accelerate next-gen RNA & DNA therapies
R&D | May 23, 2026

WACKER launches contract research services to accelerate next-gen RNA & DNA therapies

The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich


Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr
News | May 23, 2026

Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr

Transition to a fermentation-based globally integrated CDMO platform


QIAGEN and NVIDIA partner on AI drug discovery
R&D | May 21, 2026

QIAGEN and NVIDIA partner on AI drug discovery

Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases


IGI’s new drug candidate ISB 2301 to target solid tumors
Biopharma | May 20, 2026

IGI’s new drug candidate ISB 2301 to target solid tumors

The company intends to file an IND submission by the end of this year and begin clinical studies in 2027


NunaBio secures £6.5 million to scale DNA manufacturing platform
Biotech | May 19, 2026

NunaBio secures £6.5 million to scale DNA manufacturing platform

Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics